EATONTOWN, N.J., July 23, 2020 /PRNewswire/ -- Angel Medical
Systems INC is pleased to announce the appointment of Gordie Nye as its new Chief Executive Officer.
Gordie succeeds the company's founder David
Fischell, who will become the Chairman of the Board and
trusted advisor to the management team. Angel Medical Systems has
developed the AngelMed Guardian®, the first implantable, patient
alerting system designed to warn patients to seek medical attention
for Acute Coronary Syndrome (ACS) including heart attacks. Delays
in treatment contribute to the high level of mortality and
morbidity from heart attacks.
"I am truly honored to join the Angel Medical Systems team as we
prepare to enter our commercial phase. The AngelMed Guardian® is a
game changer in cardiovascular care for both acute and the
long-term management of people living with high-risk coronary
artery disease. The collective accomplishments of the company over
its 17 years are impressive. I am thrilled to begin working with
such a dedicated and talented team whose commitment to saving lives
has never wavered," said Mr. Nye.
Mr. Nye's career began at Gillette and progressed to Reebok and then LA
Gear where he spearheaded the launch of Step
Reebok™ and LA Lights™. Mr. Nye
entered the medical device field as the CEO of "A" Company
Orthodontics, a PE-backed carve out of J&J's dental division.
At "A" Company, Nye led the launch of the Damon SL, a self-ligating
bracket system that remains a category leader. After Ormco acquired
"A" Company, Mr. Nye led another carve out of a J&J business:
Critikon. Critikon's Pro Series of sub-acute patient monitors was
successfully launched and ultimately led to the acquisition of the
company by GE Medical. After several years as an angel and venture
capital investor, Mr. Nye became the CEO of ZELTIQ where he led the
creation, launch, and ultimate IPO of CoolSculpting®.
ZELTIQ arguably became the most valuable capital equipment company
in the aesthetics space. "The unifying idea throughout my diverse
career has been my passion for innovation. I can both create and
deliver a company's vision," said Nye.
"I am delighted to welcome Gordie
Nye as our new CEO. I am confident our journey to becoming a
full-fledged commercial enterprise will continue unabated," said
David Fischell, founder and
newly-appointed Chairman. "Gordie's impressive track record of
successful commercial launches and value creation is a perfect
match for all stakeholders including our employees, clinician
partners, and persons living with high risk coronary artery
disease."
About Angel Medical Systems, Inc.
Angel Medical Systems, Inc. was founded by Drs. Robert,
Tim and David Fischell to advance
life-sustaining patient care and the long-term management of
High-Risk Coronary Artery Disease. The AngelMed Guardian
System received approval by the U.S. Food and Drug Administration
(FDA) in April 2018. The AngelMed
Guardian® is an implantable cardiac monitor with patient alerting
for patients who have had prior Acute Coronary Syndromes (ACS),
including myocardial infarctions (heart attacks) or unstable angina
and who remain at high risk for recurrent ACS events.
Forward Looking Statements
Statements made in this press release that look forward in time
or that express beliefs, expectations or hopes regarding future
occurrences or anticipated outcomes or benefits are forward-
looking statements. A number of risks and uncertainties, such as
risks related to product development and commercialization efforts,
results of clinical trials, ultimate clinical outcomes and benefit
of the Company's products to patients, market and physician
acceptance of the Company's products, intellectual property
protection and competitive product offerings, could cause actual
events to differ from the expectations indicated in these
forward-looking statements. You are cautioned not to put any undue
reliance on any forward-looking statement. This press release is
neither an offer to sell nor a solicitation of an offer to purchase
any particular securities. Any such offer or solicitation will be
made only pursuant to definitive legal agreements prepared
specifically for such purpose. An investment in the Company's
securities entails significant risks and is suitable only for
sophisticated investors who can afford a loss of their entire
investment; no assurance can be given that investment objectives
will be achieved. In considering the performance information
contained herein, you should bear in mind that past performance is
not necessarily indicative of future results; there can be no
assurance that the Company will achieve comparable results or that
any projected returns will be met. The Company does not assume any
obligation to publicly update or revise any forward- looking
statements, whether as a result of new information, future events,
or otherwise.
All questions should be directed to:
Sean Pisani
Marketing Manager
spisani@angel-med.com
732.542.5551 ext. 199
View original content to download
multimedia:http://www.prnewswire.com/news-releases/angel-medical-systems-appoints-new-ceo-301099041.html
SOURCE Angel Medical Systems